Patients living with lung diseases often experience restricted breathing which causes limited mobility and loss of regular activity. Alongside pharmacotherapies, promoting activity, can not only increase quality of life for a patient but also provide healthcare professionals with a cost-effective method of treatment. Activity can be promoted through informal increased activity for a patient in everyday life or through prescribed sessions of pulmonary rehabilitation. Despite evidence supporting the benefits of activity, it is an underused intervention. In the latest instalment of ERS Vision, experts discuss how activity can decrease hospital admissions and represent cost savings, while patients share their experiences of how physical activity has improved their quality of life.
European Respiratory Society launches its latest vision to support those with respiratory health difficulties throughout europe: encouraging patients to increase their levels of activity which is proven to improve lung health.
Share this post
Latest News posts
How the UK evaluates new drugs for use in the NHS
March 4, 2025
ABPA & CPA: Patient priorities
February 25, 2025
I Have ABPA and feel worse if I sleep with windows open
February 25, 2025
How the NHS funds medications
February 25, 2025
Thinking about joining a clinical trial? What are your concerns?
December 12, 2024
Biologics & ABPA – what are they and what can they do?
October 19, 2024
UK National RSV vaccination program launched
July 26, 2024
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video